Lim Bentley, Xu Jinghua, Wierzbicki Igor H, Gonzalez Carlos G, Chen Zhe, Gonzalez David J, Gao Xiang, Goodman Andrew L
Department of Microbial Pathogenesis and Microbial Sciences Institute, Yale University School of Medicine, New Haven, CT 06536, USA.
State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
Cell Host Microbe. 2025 Feb 12;33(2):200-217.e24. doi: 10.1016/j.chom.2025.01.008. Epub 2025 Feb 4.
Antagonistic interactions play a key role in determining microbial community dynamics. Here, we report that one of the most widespread contact-dependent effectors in human gut microbiomes, Bte1, directly targets the PpiD-YfgM periplasmic chaperone complex in related microbes. Structural, biochemical, and genetic characterization of this interaction reveals that Bte1 reverses the activity of the chaperone complex, promoting substrate aggregation and toxicity. Using Bacteroides, we show that Bte1 is active in the mammalian gut, conferring a fitness advantage to expressing strains. Recipient cells targeted by Bte1 exhibit sensitivity to membrane-compromising conditions, and human gut microbes can use this effector to exploit pathogen-induced inflammation in the gut. Further, Bte1 allelic variation in gut metagenomes provides evidence for an arms race between Bte1-encoding and immunity-encoding strains in humans. Together, these studies demonstrate that human gut microbes alter the protein-folding capacity of neighboring cells and suggest strategies for manipulating community dynamics.
拮抗相互作用在决定微生物群落动态中起着关键作用。在此,我们报告称,人类肠道微生物群中最广泛存在的接触依赖性效应蛋白之一Bte1,直接靶向相关微生物中的PpiD-YfgM周质伴侣蛋白复合物。这种相互作用的结构、生化和遗传学特征表明,Bte1会逆转伴侣蛋白复合物的活性,促进底物聚集和毒性。利用拟杆菌,我们表明Bte1在哺乳动物肠道中具有活性,赋予表达菌株适应性优势。被Bte1靶向的受体细胞对膜损伤条件敏感,并且人类肠道微生物可以利用这种效应蛋白来利用肠道中病原体诱导的炎症。此外,肠道宏基因组中的Bte1等位基因变异为人类中编码Bte1的菌株和编码免疫的菌株之间的军备竞赛提供了证据。总之,这些研究表明人类肠道微生物会改变邻近细胞的蛋白质折叠能力,并提出了操纵群落动态的策略。